Schedule 13D ownership disclosure
IMPACT BIOMEDICAL INC.
Common Stock · CUSIP: 04529L106
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Heng Fai Ambrose ChanReported CIK 0001261725
Shares: 2,041,248.00 · Class: 16.9%
- Alset Inc.Reported CIK 0001750106
Shares: 2,041,248.00 · Class: 16.9%
- Alset International LimitedReported CIK 0001660984
Shares: 1,307,190.00 · Class: 10.8%
- Global Biomedical Pte. Ltd.Reported CIK 0001823066
Shares: 453,286.00 · Class: 3.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001641172-25-002493
- Form type
- SCHEDULE 13D
- Filer
- Chan Heng Fai Ambrose
- CIK
- CIK 1261725
- Filed
- Apr 02, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13D beneficial ownership